News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,580 Results
Type
Article (2859)
Company Profile (45)
Press Release (37675)
Multimedia
Podcasts (14)
Webinars (2)
Section
Business (14265)
Career Advice (79)
Deals (2129)
Drug Delivery (10)
Drug Development (4322)
Employer Resources (10)
FDA (606)
Job Trends (799)
News (20624)
Policy (1172)
Tag
Academia (146)
Accelerated approval (3)
Adcomms (1)
Allergies (7)
Alliances (3504)
ALS (6)
Alzheimer's disease (66)
Antibody-drug conjugate (ADC) (30)
Approvals (593)
Artificial intelligence (32)
Autoimmune disease (10)
Automation (2)
Bankruptcy (12)
Best Places to Work (491)
BIOSECURE Act (2)
Biosimilars (21)
Biotechnology (29)
Bladder cancer (9)
Brain cancer (9)
Breast cancer (47)
Cancer (341)
Cardiovascular disease (16)
Career advice (67)
Career pathing (1)
CAR-T (37)
CDC (3)
Cell therapy (92)
Cervical cancer (2)
Clinical research (3538)
Collaboration (202)
Company closure (2)
Compensation (105)
Complete response letters (1)
COVID-19 (213)
CRISPR (12)
C-suite (114)
Cystic fibrosis (7)
Data (421)
Denatured (6)
Depression (12)
Diabetes (19)
Diagnostics (493)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (37)
Drug pricing (15)
Drug shortages (1)
Duchenne muscular dystrophy (48)
Earnings (4532)
Editorial (11)
Employer branding (1)
Employer resources (8)
Events (6435)
Executive appointments (137)
FDA (750)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (172)
Gene editing (33)
Generative AI (1)
Gene therapy (66)
GLP-1 (76)
Government (220)
Guidances (24)
Healthcare (722)
HIV (3)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (36)
Immuno-oncology (14)
Indications (4)
Infectious disease (227)
Inflammatory bowel disease (16)
Inflation Reduction Act (7)
Influenza (9)
Intellectual property (25)
Interviews (7)
IPO (1004)
IRA (8)
Job creations (294)
Job search strategy (63)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (55)
Leadership (3)
Legal (219)
Liver cancer (8)
Longevity (1)
Lung cancer (29)
Lymphoma (13)
Machine learning (3)
Management (4)
Manufacturing (56)
MASH (16)
Medical device (325)
Medtech (326)
Mergers & acquisitions (1248)
Metabolic disorders (84)
Multiple sclerosis (23)
NASH (2)
Neurodegenerative disease (29)
Neuropsychiatric disorders (10)
Neuroscience (175)
NextGen: Class of 2026 (358)
Non-profit (155)
Now hiring (11)
Obesity (41)
Opinion (19)
Ovarian cancer (18)
Pain (28)
Pancreatic cancer (22)
Parkinson's disease (11)
Partnered (4)
Patents (55)
Patient recruitment (26)
Peanut (1)
People (5893)
Pharmaceutical (5)
Phase 1 (1511)
Phase 2 (1743)
Phase 3 (975)
Pipeline (404)
Policy (18)
Postmarket research (32)
Preclinical (645)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (16)
Rare diseases (71)
Real estate (427)
Recruiting (5)
Regulatory (1040)
Reports (7)
Research institute (152)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (2)
Schizophrenia (16)
Series A (49)
Series B (22)
Service/supplier (2)
Sickle cell disease (4)
Special edition (4)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (499)
Stomach cancer (2)
Supply chain (4)
Tariffs (3)
The Weekly (7)
Vaccines (71)
Venture capital (15)
Weight loss (27)
Women's health (11)
Worklife (1)
Date
Today (9)
Last 7 days (55)
Last 30 days (160)
Last 365 days (2482)
2026 (256)
2025 (2487)
2024 (2647)
2023 (2904)
2022 (3791)
2021 (4118)
2020 (3531)
2019 (2091)
2018 (1573)
2017 (1805)
2016 (1639)
2015 (1844)
2014 (1375)
2013 (1193)
2012 (1401)
2011 (1336)
2010 (1187)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1988)
Australia (312)
California (1609)
Canada (248)
China (82)
Colorado (55)
Connecticut (16)
Delaware (5)
Europe (4079)
Florida (65)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (3)
Indiana (61)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (49)
Massachusetts (579)
Michigan (15)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (137)
New York (82)
North Carolina (133)
Northern California (786)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (114)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (654)
Tennessee (5)
Texas (154)
United States (3243)
Utah (5)
Virginia (12)
Washington D.C. (3)
Washington State (96)
West Virginia (1)
Wisconsin (13)
40,580 Results for "greenlight biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Greenlights RevBio’s Pivotal Clinical Trial for its Cranial Flap Bone Glue
January 29, 2026
·
3 min read
Pain
Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase III for Non-Opioid Pill
The company also stands to gain from recent regulatory FDA guidance aimed at streamlining the development of non-opioid painkillers, Jefferies analysts suggested.
January 22, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
FDA Greenlights First Gene Therapy for Rare Pediatric Disease
Backed by Italy-based Fondazione Telethon ETS, Waskyra, for Wiskott-Aldrich syndrome, is the first gene therapy from a non-profit sponsor to win FDA approval.
December 10, 2025
·
1 min read
·
Tristan Manalac
Approvals
Novartis Expands Spinal Muscular Atrophy Gene Therapy Market With FDA’s Itvisma Greenlight
The FDA approved an intrathecal form of Novartis’ spinal muscular atrophy gene therapy Zolgensma on Monday, broadening access to patients two years and older in what one Stanford Medicine professor called a “game changing advance” for the field.
November 25, 2025
·
3 min read
·
Heather McKenzie
Radiopharmaceuticals
FDA’s New Radiopharma Guidance a Greenlight for an Accelerating Space
With a flurry of recent Big Pharma investment in radiopharmaceutical therapeutics, the FDA issued draft guidance last month in a move former FDA Commissioner Stephen Hahn sees as the regulator “trying to get ahead on a new set of therapy that they see becoming very important for cancer.”
September 2, 2025
·
5 min read
·
Dan Samorodnitsky
Press Releases
FDA Greenlights HDT Bio’s First-in-Class HDT-321 for the Prevention of Deadly Tick-Borne Disease
September 22, 2025
·
5 min read
FDA
2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US
Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s greenlight for an injectable formulation of BMS’s cancer blockbuster.
January 2, 2025
·
2 min read
·
Kate Goodwin
FDA
6 FDA Decisions To Watch in Q1 2026
After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after being delayed from the fourth quarter last year.
January 12, 2026
·
8 min read
·
Tristan Manalac
Brain cancer
FDA Greenlights Jazz’s Dordaviprone, First New Treatment for Ultra-Rare Brain Tumor
The small molecule drug, acquired by Jazz Pharmaceuticals in its $935 million Chimerix pick-up this spring, is intended for relapsed adult and pediatric patients with H3 K27M mutations.
August 6, 2025
·
2 min read
·
Dan Samorodnitsky
Genetown
GreenLight Biosciences Secures EPA Registration for New Bioinsecticide, Calantha, Historic Step Towards A Safer and More Sustainable Food System
GreenLight Biosciences (GreenLight Bio) has been granted registration by the U.S. Environmental Protection Agency (EPA) and several states for its groundbreaking Calantha™ product, designed to target and control the highly destructive Colorado potato beetle.
January 4, 2024
·
5 min read
1 of 4,058
Next
